AEMPS authorizes Phase IIb clinical trial of HIPRA Covid-19 vaccine
The biotechnological pharmaceutical company HIPRA has received authorization from the Spanish Agencyfor Medicines and Health Products (AEMPS) to sta1
News about Hipra
The clinical trial of the HIPRA vaccine against COVID-19 is progressing with the administration of the first doses to humans
This week the vaccine began to be administered to the first volunteers participating in Phase I/IIa of the trial at the Hospital Trueta in Girona and1
Are you between 18 and 39 years old and do you want to take part in a PHASE I trial of a new COVID-19 vaccine?
HIPRA (Amer, Girona) is looking for volunteers aged between 18 and 39 who have not received any COVID-19 vaccine and who have not had the infection,1